Results 161 to 170 of about 5,603,984 (294)

Benefits of Strict Glucose and Blood Pressure Control in Type 2 Diabetes [PDF]

, 1999
Markku Laakso
openalex   +1 more source

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

New England Journal of Medicine, 2016
C. Wanner, S. Inzucchi, J. Lachin, D. Fitchett, M. von Eynatten, M. Mattheus, O. Johansen, H. Woerle, U. Broedl, B. Zinman   +9 more
semanticscholar   +1 more source

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction [PDF]

, 1998
Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälà, Markku Laakso   +4 more
openalex   +1 more source

Early Versus Late Diagnosis of Youth-Onset Type 2 Diabetes. [PDF]

Endocrinol Diabetes Metab
Krishnan N, Crimmins NA, Swertfeger D, Schaaf L, Shah AS.   +4 more
europepmc   +1 more source

Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity¹ [PDF]

, 1998
Robert Hogikyan, Andrzej T. Gałecki, Bertram Pitt, Jeffrey B. Halter, Douglas A. Greene, Mark A. Supiano   +5 more
openalex   +1 more source

Heterogeneity of type 2 diabetes in rural India. [PDF]

Front Endocrinol (Lausanne)
Patil S, Patil A, Tare K, Bhat P, Kumbhar A, Mulay D, Jadhav D, Methi V, Surnar S, Humbare T, Khaladkar A, Deosale S, Joglekar C.   +12 more
europepmc   +1 more source

Cardiometabolic HFpEF with focus on type 2 diabetes mellitus. [PDF]

Cardiovasc Diabetol
Gorica E, Paneni F.
europepmc   +1 more source

Treatment of type 2 diabetes in youth: An argument for randomized controlled studies [PDF]

, 1999
Heather Dean
openalex   +1 more source

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

New England Journal of Medicine, 2001
E. Lewis, L. Hunsicker, W. Clarke, T. Berl, M. Pohl, J. Lewis, E. Ritz, R. Atkins, R. Rohde, I. Raz   +9 more
semanticscholar   +1 more source

Type 2 diabetes mellitus: Isn't it time to update the terminology? [PDF]

World J Diabetes
Raveendran AV.
europepmc   +1 more source